Arrowstreet Capital’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.6M Buy
100,987
+6,972
+7% +$288K ﹤0.01% 1052
2026
Q2
$3.66M Buy
+94,015
New +$3.66M ﹤0.01% 1384
2023
Q3
– Sell
-94,432
Closed -$652K – 1337
2023
Q2
$652K Buy
94,432
+69,315
+276% +$424K ﹤0.01% 1032
2023
Q1
$156K Buy
25,117
+12,616
+101% +$88.3K ﹤0.01% 1305
2022
Q4
$90K Buy
+12,501
New +$89.7K ﹤0.01% 1294
2020
Q3
– Sell
-10,400
Closed -$563K – 2421
2020
Q2
$563K Buy
+10,400
New +$587K ﹤0.01% 1934

Other funds holding KOD

Arrowstreet Capital's KOD Position: Q3 2026 in Review

Arrowstreet Capital increased its Kodiak Sciences (KOD) stake by 7.4% in Q3 2026, buying an estimated $288K and bringing the position to 100,987 shares worth $9.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Arrowstreet Capital first reported a position in KOD in Q2 2020 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold KOD as of Q3 2026.

  • Arrowstreet Capital held 100,987 shares of Kodiak Sciences worth $9.6M as of Q3 2026.
  • Arrowstreet Capital bought 6,972 Kodiak Sciences shares in Q3 2026, an estimated $288K.
  • Kodiak Sciences made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1052 holding.
  • Arrowstreet Capital first reported a position in Kodiak Sciences in Q2 2020 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Kodiak Sciences as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.